1. Home
  2. ICUCW vs SIGA Comparison

ICUCW vs SIGA Comparison

Compare ICUCW & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • SIGA
  • Stock Information
  • Founded
  • ICUCW N/A
  • SIGA 1995
  • Country
  • ICUCW United States
  • SIGA United States
  • Employees
  • ICUCW 12
  • SIGA N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • SIGA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICUCW Health Care
  • SIGA Health Care
  • Exchange
  • ICUCW Nasdaq
  • SIGA Nasdaq
  • Market Cap
  • ICUCW N/A
  • SIGA N/A
  • IPO Year
  • ICUCW 2021
  • SIGA 1997
  • Fundamental
  • Price
  • ICUCW $0.04
  • SIGA $6.50
  • Analyst Decision
  • ICUCW
  • SIGA
  • Analyst Count
  • ICUCW 0
  • SIGA 0
  • Target Price
  • ICUCW N/A
  • SIGA N/A
  • AVG Volume (30 Days)
  • ICUCW N/A
  • SIGA 585.4K
  • Earning Date
  • ICUCW N/A
  • SIGA 05-06-2025
  • Dividend Yield
  • ICUCW N/A
  • SIGA 9.30%
  • EPS Growth
  • ICUCW N/A
  • SIGA N/A
  • EPS
  • ICUCW N/A
  • SIGA 0.82
  • Revenue
  • ICUCW N/A
  • SIGA $138,719,350.00
  • Revenue This Year
  • ICUCW N/A
  • SIGA N/A
  • Revenue Next Year
  • ICUCW N/A
  • SIGA $95.35
  • P/E Ratio
  • ICUCW N/A
  • SIGA $7.87
  • Revenue Growth
  • ICUCW N/A
  • SIGA N/A
  • 52 Week Low
  • ICUCW N/A
  • SIGA $4.95
  • 52 Week High
  • ICUCW N/A
  • SIGA $12.83
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • SIGA 66.40
  • Support Level
  • ICUCW N/A
  • SIGA $5.83
  • Resistance Level
  • ICUCW N/A
  • SIGA $6.54
  • Average True Range (ATR)
  • ICUCW 0.00
  • SIGA 0.32
  • MACD
  • ICUCW 0.00
  • SIGA 0.07
  • Stochastic Oscillator
  • ICUCW 0.00
  • SIGA 97.22

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: